Valuation : DNA X, Inc.

Market Cap 5.25M 4.53M 4.26M 3.88M 7.29M 498M 7.33M 50.32M 19.59M 253M 19.7M 19.27M 840M P/E 2024
-0.44x
P/E 2025 -0.11x
Enterprise Value 9.01M 7.77M 7.31M 6.66M 12.52M 855M 12.59M 86.41M 33.63M 435M 33.82M 33.09M 1.44B EV / Sales 2024
0.17x
EV / Sales 2025 -
Free-Float
65.23%
Yield 2024 *
-
Yield 2025 -
1 day-3.69%
1 week+7.96%
Current month-3.69%
1 month+3.92%
3 months-25.48%
6 months-35.20%
Current year+11.90%
1 week 2.92
Extreme 2.925
3.7
1 month 2.92
Extreme 2.925
4.3
Current year 2.62
Extreme 2.62
7.97
1 year 2.52
Extreme 2.5211
16.97
3 years 2.52
Extreme 2.5211
192.6
5 years 2.52
Extreme 2.5211
1,322.28
10 years 2.52
Extreme 2.5211
32,863.47
Manager TitleAgeSince
Chief Executive Officer 63 2026-02-08
Director of Finance/CFO 64 2022-07-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 63 2023-11-12
Director/Board Member 64 2022-07-12
Director/Board Member 79 2022-07-12
Date Insider Type Main position Quantity % Market Cap. Importance
2/9/26 Free

Chief Executive Officer

50,000 3.3592%
2/9/26 Free

Chief Financial Officer

35,000 2.3514%
7/18/25 Other

Director

723 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-3.69%+7.96%-66.48%-97.00% 5.25M
+0.38%+1.56%+286.09%+267.61% 1,208B
+1.16%+1.69%-22.77%+32.78% 1.77B
-5.31%+2.52%+16.91%+174.03% 1.32B
+1.74%+0.99%-43.90%-21.50% 1.08B
+1.07%-3.21%+53.88%-7.00% 939M
-0.80%-2.02%+17.67%+107.10% 827M
+10.04%+13.07%+16.27%+20.24% 550M
-0.88%-0.97%-5.80%+56.55% 545M
-0.18%+4.01%-47.60%+74.68% 140M
Average +0.39%+2.03%+20.43%+60.75% 121.54B
Weighted average by Cap. +0.38%-0.18%+284.40%+266.35%

Financials

2024 2025
Net sales 58.3M 50.29M 47.3M 43.09M 81.04M 5.53B 81.48M 559M 218M 2.81B 219M 214M 9.33B -
Net income -33.65M -29.02M -27.3M -24.87M -46.77M -3.19B -47.03M -323M -126M -1.62B -126M -124M -5.39B -20.66M -17.82M -16.76M -15.27M -28.71M -1.96B -28.87M -198M -77.12M -997M -77.56M -75.88M -3.31B
Net Debt -5.34M -4.61M -4.34M -3.95M -7.43M -507M -7.47M -51.25M -19.95M -258M -20.06M -19.63M -855M 3.76M 3.25M 3.05M 2.78M 5.23M 357M 5.26M 36.09M 14.05M 182M 14.12M 13.82M 602M
Logo DNA X, Inc.
DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.
Employees
4
Date Price Change Volume
26-09-01 $3.525 -3.69% 3,357
26-08-31 $3.660 +5.78% 8,250
26-08-28 $3.460 +5.81% 9,943
26-08-27 $3.270 +1.87% 15,208
26-08-26 $3.210 -1.68% 5,200

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SONM Stock